Abbott Grabs Ibis’ T5000 Biosensor System For Infectious Disease Diagnostics

Abbott will focus on developing molecular diagnostics for hospital-acquired infections using Ibis Biosciences' T5000 biosensor system after acquiring the business for $215 million